Regulatory Filings • Mar 7, 2022
Regulatory Filings
Open in ViewerOpens in native device viewer
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action you should take, you should consult your accountant, legal or professional adviser, financial adviser or a person authorised for the purposes of the Financial Services and Markets Act 2000, as amended, (FSMA) who specialises in advising on the acquisition of shares and other securities.
This document comprises a supplementary prospectus relating to Bluefield Solar Income Fund Limited (the Company) for the purposes of Article 23 of the UK version of the EU Prospectus Regulation (2017/1129) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018 (as amended and supplemented from time to time (including, but not limited to, by the UK Prospectus Amendment Regulations 2019 and The Financial Services and Markets Act 2000 (Prospectus) Regulations 2019)) (the UK Prospectus Regulation) and the prospectus regulation rules of the Financial Conduct Authority (the FCA) (the Prospectus Regulation Rules). This Supplementary Prospectus has been approved by the FCA, as the competent authority under the UK Prospectus Regulation. The FCA only approves this Supplementary Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the UK Prospectus Regulation. Accordingly, such approval should not be considered as an endorsement of the issuer, or of the quality of the securities, that are the subject of the Prospectus (as defined below). Investors should make their own assessment as to the suitability of investing in the New Ordinary Shares.
This Supplementary Prospectus is supplemental to, and should be read in conjunction with the prospectus published by the Company on 29 June 2021 and the first supplementary prospectus dated 14 February 2022 in relation to the publication of the Company's annual report and audited financial statements for the financial year ended 30 June 2021 (the Prospectus) in connection with the issues of up to 127.1 million New Ordinary Shares by way of an initial placing, open offer and offer for subscription (the Initial Issue) and a subsequent placing programme of up to 500 million New Ordinary Shares (less the number of New Ordinary Shares issued pursuant to the Initial Issue) (the Placing Programme).
Words or expressions defined in the Prospectus have the same meaning when used in this Supplementary Prospectus unless the context requires otherwise. Persons receiving this Supplementary Prospectus should read the Prospectus as a whole.
The Company and the Directors, whose names appear on page 42 of the Prospectus (other than Mr Laurence McNairn who resigned as a Director of the Company with effect from 17 February 2022), accept responsibility for the information contained in this Supplementary Prospectus. To the best of the knowledge of the Company and the Directors, the information contained in this Supplementary Prospectus is in accordance with the facts and does not omit anything likely to affect the import of such information.
(a company incorporated in Guernsey under The Companies (Guernsey) Law, 2008, as amended, with registered number 56708)
Sponsor, Broker and Financial Adviser Numis Securities Limited
Numis Securities Limited (Numis), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no-one else in connection with the Placing Programme and the other matters referred to in the Prospectus and this Supplementary Prospectus and will not regard any other person (whether or not a recipient of the Prospectus or this Supplementary Prospectus) as its client in relation to the Placing Programme and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing Programme, the contents of this Supplementary Prospectus or any transaction or arrangement referred to in the Prospectus. This does not exclude any responsibilities or liabilities of Numis under FSMA or the regulatory regime established thereunder.
This Supplementary Prospectus does not contain or constitute an offer to sell or to issue any New Ordinary Shares or the solicitation of an offer to buy or subscribe for New Ordinary Shares in any jurisdiction including, without limitation, the United States, Australia, Canada or the Republic of South Africa or any other jurisdiction in which such offer or solicitation is or may be unlawful (an Excluded Territory). The distribution of this Supplementary Prospectus in certain jurisdictions may be restricted by law and this Supplementary Prospectus and the information contained herein are not for publication or distribution, directly or indirectly, to persons in an Excluded Territory unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction. No action has been taken by the Company or Numis that would permit an offer of the New Ordinary Shares or possession or distribution of this Supplementary Prospectus or any other offering or publicity material in any jurisdiction where action for that purpose is required. Persons into whose possession this Supplementary Prospectus comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.
The New Ordinary Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the U.S. Securities Act), or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to or for the account or benefit of any U.S. Person (within the meaning of Regulation S under the U.S. Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction in the United States. In addition, the Company has not been, and will not be, registered under the United States Investment Company Act of 1940, as amended (the U.S. Investment Company Act), nor will the Investment Adviser be registered under the United States Investment Advisers Act of 1940, as amended (the U.S. Investment Advisers Act), and investors will not be entitled to the benefits of the U.S. Investment Company Act or the U.S. Investment Advisers Act.
The attention of potential investors is drawn to the Risk Factors set on pages 11 to 32 of the Prospectus.
7 March 2022
This document constitutes a Supplementary Prospectus required under Prospectus Regulation Rules 3.4.1 and 3.4.2 following the publication on 22 February 2022 of the Company's unaudited interim report and financial statements for the half-year ended 31 December 2021 (the December 2021 Interim Report), which constitutes a significant new factor relating to the financial information contained in the Prospectus.
A copy of the December 2021 Interim Report has been filed with the Financial Conduct Authority and, by virtue of this Supplementary Prospectus, such December 2021 Interim Report is partly incorporated in, and forms part of, the Prospectus. This Supplementary Prospectus is also being published to update the Prospectus summary to include key historical financial information contained within the December 2021 Interim Report.
On 22 February 2022, the Company published the December 2021 Interim Report.
By virtue of this Supplementary Prospectus, the unaudited financial statements relating to the Company for the half year from 1 July 2021 to 31 December 2021 are incorporated into the Prospectus by reference to the December 2021 Interim Report, as set out in section 3 below and form part of the Prospectus.
The December 2021 Interim Report which is incorporated into this Supplementary Prospectus by reference (and the parts of the December 2021 Interim Report that are not referred to below are not relevant to investors or are covered elsewhere in the Prospectus, as amended and supplemented by this Supplementary Prospectus) included, on the pages specified in the table below, the following information:
| Half-yearly report for period ended 31 December 2021 (unaudited) (Page No(s)) |
|
|---|---|
| Balance sheet | 51 |
| Income statement | 52 |
| Statement of changes in shareholders' equity | 53 |
| Cash flow statement | 54 |
| Accounting policies | 55 – 56 |
| Notes to the accounts | 55 – 65 |
| Chairman's statement | 7 – 10 |
| Report of the Investment Adviser | 13 – 38 |
The key unaudited figures that summarise the Company's financial condition in respect of the half-year ended 31 December 2021 which have been extracted directly from the December 2021 Interim Report and the corresponding figures for the half-year ended 31 December 2020 extracted directly from the half-year report for the period ended 31 December 2020, are set out in the following table:
| Half-Year ended 31 December 2021 (unaudited) |
Half-Year ended 30 31 December 2020 (unaudited) |
|
|---|---|---|
| Net assets (£'000) | 609,975 | 476,672 |
| Net asset value per share (pence) | 12296 | 117.12 |
| Total operating income (£'000) | 54,511 | 14,189 |
| Profit and comprehensive income for the period (£'000) | 53,699 | 13,485 |
| Earnings per share (pence) 1 | 11.05 | 3.57 |
| Dividends per share (pence) | 2.03 | 2.00 |
As a result of the publication of the December 2021 Interim Report, Tables 1, 2 and 3 of the section of the Prospectus entitled "Summary" are hereby amended and restated as follows:
| Share Class | Total NAV (£m)* |
Number of Shares* |
NAV per share (p)* |
Historical performance of the Company |
|---|---|---|---|---|
| Ordinary Shares |
610.0 | 496,067,602 | 122.96 | During the period from 1 July 2021 to 31 December 2021, the Company delivered a NAV total return of 5.68 per cent., measured as the movement in NAV plus dividends over the period. Dividends for the period totaled 2.03 pence per Ordinary Share. The value of the Company's investments as at 31 December 2021 was £610.0 million. As at 31 December 2021, the Company's NAV per Ordinary Share was 122.96 pence and its Ordinary Share price was 124.3 pence. |
* as at 31 December 2021
| Year ended 30 June | Half-year ended 31 December |
||||
|---|---|---|---|---|---|
| 2019 | 2020 | 2021 | 2020 | 2021 | |
| Total Income (£'000) | 46,892 | 29,578 | 25,921 | 14,189 | 54,511 |
| Net profit/(loss) (£'000) | 44,925 | 28,240 | 24,517 | 13,485 | 53,699 |
| Performance fee (£'000) | 699 | - | - | - | - |
| Investment Advisory Fee (accrued/paid) (£'000) |
313 | 321 | 363 | 170 | 236 |
| Any other material fees to service providers (£'000) |
873 | 918 | 985 | 514 | 542 |
| Earnings per share (pence) | 12.15 | 7.63 | 6.25 | 3.57 | 11.05 |
| Year ended 30 June | Half-year ended 31 December |
||||
|---|---|---|---|---|---|
| 2019 | 2020 | 2021 | 2020 | 2021 | |
| Total Net Assets (£'000) | 436,396 | 433,505 | 471,425 | 476,672 | 609,975 |
| Leverage Ratio* (%) | 34 | 35 | 44 | 37 | 35 |
* Total liabilities divided by total net assets.
As a result of the publication of the December 2021 Interim Report, paragraph 8 of Part XI of the Prospectus is amended and restated as follows:
"There has been no significant change in the financial position of the Group since 31 December 2021 (being the end of the last financial period of the Company for which unaudited financial information has been published) save for:
In accordance with Article 23(2) of the UK Prospectus Regulation, investors who have agreed before this Supplementary Prospectus was published to purchase or subscribe for the Company's shares pursuant to an offer to the public, where the allotment of which had not become fully unconditional, would have the right to withdraw their acceptances. As the Open Offer and Offer for Subscription that were made pursuant to the Prospectus expired on 23 July 2021, there is no offer to the public being made pursuant to the Prospectus that has not become fully unconditional as at the date of this Supplementary Prospectus. As such, the withdrawal rights pursuant to Article 23(2) of the UK Prospectus Regulation are not applicable in the context of this Supplementary Prospectus.
inaccuracy relating to information included in the Prospectus has arisen or been noted, as the case may be, since the publication of the Prospectus.
7.4 In the event of any inconsistency between the Prospectus and this Supplementary Prospectus, this Supplementary Prospectus shall prevail.
7 March 2022
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.